- Home
- CTM vs ABOS Comparison
CTM vs ABOS Comparison
Compare CTM & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTM
- ABOS
- Stock Information
- Founded
- CTM 2019
- ABOS 1996
- Country
- CTM United States
- ABOS United States
- Employees
- CTM N/A
- ABOS N/A
- Industry
- CTM EDP Services
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- CTM Technology
- ABOS Health Care
- Exchange
- CTM Nasdaq
- ABOS Nasdaq
- Market Cap
- CTM 103.2M
- ABOS 84.2M
- IPO Year
- CTM N/A
- ABOS 2021
- Fundamental
- Price
- CTM $1.12
- ABOS $1.26
- Analyst Decision
- CTM Strong Buy
- ABOS Strong Buy
- Analyst Count
- CTM 1
- ABOS 3
- Target Price
- CTM $3.00
- ABOS $8.00
- AVG Volume (30 Days)
- CTM 2.2M
- ABOS 182.5K
- Earning Date
- CTM 11-12-2025
- ABOS 11-11-2025
- Dividend Yield
- CTM N/A
- ABOS N/A
- EPS Growth
- CTM N/A
- ABOS N/A
- EPS
- CTM N/A
- ABOS N/A
- Revenue
- CTM $47,595,866.00
- ABOS N/A
- Revenue This Year
- CTM $22.99
- ABOS N/A
- Revenue Next Year
- CTM $3.68
- ABOS N/A
- P/E Ratio
- CTM N/A
- ABOS N/A
- Revenue Growth
- CTM 4.17
- ABOS N/A
- 52 Week Low
- CTM $0.13
- ABOS $0.86
- 52 Week High
- CTM $2.83
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- CTM 50.71
- ABOS 41.28
- Support Level
- CTM $1.07
- ABOS $1.34
- Resistance Level
- CTM $1.16
- ABOS $1.47
- Average True Range (ATR)
- CTM 0.06
- ABOS 0.08
- MACD
- CTM 0.01
- ABOS -0.01
- Stochastic Oscillator
- CTM 68.42
- ABOS 12.50
About CTM Castellum Inc.
Castellum Inc is engaged in providing information technology services. The company provides financial services, healthcare, and other users of large data applications with services that include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and MBSE. In addition to constantly innovating and enhancing organic capabilities, Castellum is acquiring technology companies in the areas of cybersecurity, information technology, electronic warfare, information warfare, and information operations with businesses in the defense, federal, civilian, and commercial markets.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.